The Indian market provides significant growth opportunities for the pharma industry. However, for the industry to sustain a robust growth rate of 15-20% till 2020, companies will have to rethink the way they have been doing business.
The joint CII-PwC report looks at the different types of growth levers that have fuelled the growth of the Indian market, emerging new business models, as well as the key success factors that need to be kept in mind to achieve sustainable long term growth. It presents an overview of some of the issues facing the pharma industry today and throws light on the road ahead for all stakeholders, to realize its full potential.
The report was released at the 10th Pharma Summit 2012 organised by CII on 05 November, 2012 at Ahmedabad.